SP-420 in Subjects With Transfusion-dependent Beta-Thalassemia or Other Rare Anemias

PHASE2WithdrawnINTERVENTIONAL

Timeline

Start Date

August 31, 2020

Primary Completion Date

September 30, 2022

Study Completion Date

January 31, 2023

Conditions

Iron OverloadBeta-Thalassemia

Interventions

DRUG

SP-420

Self-administered by mouth

Trial Locations (4)

University of Toronto- University Health Network, Toronto

American University of Beirut Medical Center, Beirut

Siriraj Hospital, Bangkok

Ege University Hospital, Izmir